CNS tumors with YWHAE:NUTM2 and KDM2B-fusions present molecular similarities to extra-CNS tumors having BCOR internal tandem duplication or alternative fusions

[1]  P. Varlet,et al.  BCOR immunohistochemistry, but not SATB2 immunohistochemistry, is a sensitive and specific diagnostic biomarker for central nervous system tumours with BCOR internal tandem duplication , 2021, Histopathology.

[2]  M. Ladanyi,et al.  Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma , 2020, Modern Pathology.

[3]  S. Matsumoto,et al.  Identification of Novel Fusion Genes in Bone and Soft Tissue Sarcoma and Their Implication in the Generation of a Mouse Model , 2020, Cancers.

[4]  D. Lin,et al.  Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss. , 2020, Gynecologic oncology.

[5]  M. Aboian,et al.  High‐grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication—a comprehensive clinical, radiographic, pathologic, and genomic analysis , 2019, Brain pathology.

[6]  A. Pession,et al.  BCOR involvement in cancer , 2019, Epigenomics.

[7]  Y. Arakawa,et al.  CNS high‐grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue , 2018, Brain pathology.

[8]  Publisher's Note , 2018, Anaesthesia.

[9]  M. Kool,et al.  HGNET-BCOR Tumors of the Cerebellum: Clinicopathologic and Molecular Characterization of 3 Cases , 2017, The American journal of surgical pathology.

[10]  M. Ladanyi,et al.  BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology , 2017, Modern Pathology.

[11]  M. Gessler,et al.  Mutually exclusive BCOR internal tandem duplications and YWHAE‐NUTM2 fusions in clear cell sarcoma of kidney: not the full story , 2016, The Journal of pathology.

[12]  Roland Eils,et al.  New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs , 2016, Cell.